ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2054

Efficacy and Safety Of Low-Intensity Resistance Training Combined With Vascular Occlusion In Polymyositis and Dermatomyositis

Melina Mattar1, Luiz A. Perandini1, Thalita Dassouki2, Samuel K. Shinjo1, Bruno Gualano3, Hamilton Roschel3, Fernanda R. Lima4 and Ana Lucia S. Pinto1, 1University of Sao Paulo, Rheumatology Division, LACRE, Sao Paulo, Brazil, 2Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 3University of Sao Paulo, School of Physical Education and Sport, Sao Paulo, Brazil, 4University of Sao Paulo, Rheumatology Division, Sao Paulo, Brazil

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: exercise, Muscle strength, myositis and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Muscle Biology, Myositis and Myopathies: Advances in the Epidemiology, Immunology and Therapy of Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Previous studies have demonstrated that low-intensity resistance training combined with vascular occlusion (VO) improves muscle strength to the magnitude of traditional high-intensity resistance training in healthy subjects. We, therefore, aimed to determine whether low-intensity resistance training combined with VO is safe and effective to improve muscle strength, functional capacity and quality of life in patients with polymyositis (PM) and dermatomyositis (DM).

Methods: Thirteen patients (4 PM and 9 DM according to Bohan and Peter’s criteria, 1975) from the Outpatient Myopathy Unit of our tertiary Center, with complete clinical response to the treatment (age: 45.6±8.8 years; disease duration: 5.4±2.9 years; body mass index (BMI): 31.0±6.6kg/m2; VO2max: 23.3±6.9mL/kg/min) were submitted to a 12-week supervised exercise program that consisted of resistance exercises at low-intensity [30% of one repetition maximum (1RM)] combined with VO (70% of the total occlusion pressure of the tibial posterior artery). Clinical questionnaires [36-item short form health survey (SF-36), the health assessment quality (HAQ) and the visual analogue scale (VAS)], muscle strength (1RM of leg press and leg extension), functional capacity [time stands (TS) and timed up and go (TUG) tests] and serum muscle enzymes were assessed before (PRE) and after (POST) the exercise program. The pharmacological treatment remained unchanged at least three months prior to study entry and throughout the protocol.

Results: Comparison of pre- and post-exercise intervention revealed that all patients had significant improvements in muscle strength (leg-press: 128±62 vs. 155±78kg, P=0.001; leg-extension: 37±10 vs. 46±13kg, P=0.001) and muscle function (TS: 13±2 vs. 15±2, P=0.001; TUG: 6.9±1.1 vs. 6.6±1.0s, P=0.002). Additionally, improvement in quality of life, as measured by the SF-36 (Physical component: 41.6±7.2 vs. 50.0±7.4, P=0.001; Mental component: 42.7±13.0 vs. 56.0±10.1, P = 0.008), HAQ (1.58±1.98 vs. 0.60±0.62, P=0.007) and VAS (VAS patient: 4.6±2.9 vs. 1.6±1.2cm, P=0.024; VAS physician: 2.7±1.2 vs. 1.2±0.6cm, P=0.001). Of note, no change in serum levels of creatine kinase (195±76 vs. 224±171IU/L, P=0.944) and aldolase (3.9±1.5 vs. 3.1±1.6IU/L, P=0.265).

Conclusion: The present work provides novel evidence that a low-intensity resistance training program combined with VO is safe and effective in improving muscle strength, functional capacity, and quality of life in PM and DM patients.


Disclosure:

M. Mattar,
None;

L. A. Perandini,
None;

T. Dassouki,
None;

S. K. Shinjo,
None;

B. Gualano,
None;

H. Roschel,
None;

F. R. Lima,
None;

A. L. S. Pinto,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/efficacy-and-safety-of-low-intensity-resistance-training-combined-with-vascular-occlusion-in-polymyositis-and-dermatomyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology